Stent-Retriever for Acute Massive Pulmonary Embolism (SRAME)
NCT05992168 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1
Last updated 2025-09-18
Summary
To evaluate treatment outcomes of patients diagnosed with pulmonary embolism.
Conditions
- PE - Pulmonary Embolism
- PE - Pulmonary Thromboembolism
Interventions
- DEVICE
-
Stent-Retriever
all the participants in this group will be performed with Stent-Retriever
Sponsors & Collaborators
-
Suzhou Zenith Vascular Scitech Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-03
- Primary Completion
- 2024-12-17
- Completion
- 2024-12-17
Countries
- China
Study Locations
More Related Trials
-
tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden
NCT04248868 ·Status: COMPLETED ·Phase: PHASE3
-
Catheter Thrombectomy in Patients With Massive Pulmonary Embolism
NCT00314002 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients
NCT00571649 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Study for the Outpatient Treatment of Patients With Very Low Risk Acute Symptomatic Pulmonary Embolism.
NCT05852119 ·Status: RECRUITING ·Phase: NA
-
Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 1 of 4)
NCT01758432 ·Status: COMPLETED ·Phase: PHASE2
-
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
NCT05794165 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE
NCT00558259 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study
NCT06073366 ·Status: COMPLETED
-
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
NCT04558125 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
NCT04263038 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients
NCT06487052 ·Status: RECRUITING ·Phase: NA
-
Mortality Due to Malignancy in Patients With Idiopathic Venous Thromboembolism
NCT01088334 ·Status: TERMINATED
-
Prophylactic Anticoagulation for Catheter-related Thrombosis
NCT04256525 ·Status: UNKNOWN ·Phase: PHASE4
-
Personalized Anticoagulant Therapy for Pulmonary Thromboembolism
NCT06341231 ·Status: RECRUITING
-
Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter
NCT06975969 ·Status: WITHDRAWN
-
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism
NCT04168203 ·Status: COMPLETED ·Phase: PHASE4
-
YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness
NCT01028950 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Thrombolytic Effect of Platelet Membrane Coated Recombinant Staphylokinase on Human Arterial Thrombus
NCT05978791 ·Status: RECRUITING
-
Left Atrial Appendage Occlusion vs. Usual Care in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
NCT02039167 ·Status: TERMINATED ·Phase: NA
-
Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE
NCT05172115 ·Status: TERMINATED ·Phase: PHASE3
-
Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes
NCT02556203 ·Status: TERMINATED ·Phase: PHASE3
-
Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD
NCT01531829 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
NCT02164864 ·Status: COMPLETED ·Phase: PHASE3
-
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
NCT03568890 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy
NCT02836652 ·Status: COMPLETED ·Phase: PHASE4